abstract |
The present invention features compounds of e.g. formula I effective in inhibiting Hepatitis C virus ("HCV") polymerase. The invention also features compositions comprising such compounds and methods of using such compounds to treat HCV infection. (Formula I), In formula I e.g. R3 is CF2H; R2 is CCF, CCH or CN. |